THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.1% of their position (110K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 6/24/2022ACC: 0001493152-22-017718
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-110K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
110K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−80K
Price / share
—
Trade value
—
% of position
0.0%
6/23/2022
202.35M→202.27M
Common Stock
Direct
Shares
−30K
Price / share
—
Trade value
—
% of position
0.0%
6/24/2022
202.27M→202.24M
Total
Net shares
−110K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2022 | S · Sale | −80K | — | — | 0.0% | 202.35M | 202.27M |
| Common Stock Direct | 6/24/2022 | S · Sale | −30K | — | — | 0.0% | 202.27M | 202.24M |
| Total | −110K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported